Submitted by Anonymous (not verified) on 14 July 2025 - 15:57
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 13, Status: Authorised